For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250214:nRSN2377Xa&default-theme=true
RNS Number : 2377X UIL Limited 14 February 2025
14 February 2025
UIL LIMITED
(LEI Number: 213800CTZ7TEIE7YM468)
Publication of monthly factsheet
The latest monthly factsheet for UIL Limited ("UIL" or the "Company") will
shortly be available through the Company's website at:
https://www.uil.limited/investor-relations/factsheet-archive
(https://www.uil.limited/investor-relations/factsheet-archive)
Monthly commentary
PERFORMANCE
UIL's net asset value ("NAV") total return increased by 4.8% in January,
largely in line with the performance of the FTSE All Share total return Index
which increased by 5.5% over the month.
Donald Trump was inaugurated as President of the United States and as in prior
months, speculation about his administration's policies dominated investor
sentiment globally. The level of uncertainty, especially with regards to
import tariffs, trade and foreign policy remained high. The release of
DeepSeek, a rival to ChatGPT, developed by a Chinese company reportedly using
lower computing power intrigued the market, posing questions about America's
lead in AI technology and future demand for the latest Nvidia processor chips.
Generally, developed markets were positive during January. The S&P 500
Index advanced by 2.7% in the month, the FTSE 100 Index was up by 6.1%, the
Eurostoxx Index increased by 8.0% and the Australian ASX 200 Index gained
4.6%. The US Federal Reserve held rates as expected at its January meeting,
whilst the European Central Bank and Bank of England had their first meetings
of the year scheduled for early February, with rate cuts by both institutions
expected.
In the emerging markets, the wait continues for tangible signs of China's
stimulus measures. Southeast Asian markets were weak, notably in the
Philippines where the PSEI Index declined by 10.2% in January. In contrast
Latin America saw a positive return of investor confidence despite lingering
concerns over possible US import tariffs.
Commodity prices firmed, with gold moving up by 6.6% in the month to almost
USD 2,800/oz and Brent Crude oil was up by 2.8%. Copper was also up during
January by 6.3%.
PORTFOLIO UPDATE
UIL's top ten holdings are disclosed on a look through basis, taking into
account the underlying
investments of Somers Limited and Zeta Resources Limited. There were no
changes to the constituents of the top ten holdings in January 2025.
Resimac remains the largest holding on a look through basis, and its share
price was up by 6.3% during the month. UIL offered to buy the listed
minorities of Carebook Technologies and aims to take the company private
during February. Carebook's share price rose by 137.5% during the month.
ORDINARY SHARES
The share price of the ordinary shares was up by 5.9% to 116.50p in January.
There were no buybacks during the month.
A quarterly interim dividend of 2.00p per ordinary share in respect of the
year ending 30 June 2025, was paid on 17 January 2025 to shareholders on the
register on 3 January 2025.
ZDP SHARES
The share price of the 2026 ZDP shares was unchanged whilst the 2028 ZDP
shares decreased by 3.1% during the month.
Name of contact and telephone number for enquiries:
Charles Jillings
ICM Investment Management
Limited
+44(0)1372 271486
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DOCSFAFILEISELE